DefinedHealth

Ed Saltzman

Ed Saltzman’s Feeding the Pipeline presentations began in 2000 to document the limitations of Big Pharma’s intense stampede for an incredibly shrinking number of late-stage product opportunities. Over the years, Ed’s presentation has evolved to examine the ever-increasing strategic challenges and responsibilities faced by Pharma and Biotech Licensing Executives. This year’s presentation, Feeding the Pipeline V: Dealing for Mutualism will consider the role of L&BD executives within the current context of unprecedented challenges to the industry.

Pharma’s foray into specialty markets is, at once, encroaching on a territory largely occupied by biotech, creating an imperative for the development of new win-win deal structures with biotech, and forcing consolidation within the biotech sector. Franchise focus to gain competitive advantage across the discovery-development-commercial spectrum will be paramount to success and survival.

Feeding the Pipeline V: Dealing for Mutualism will consider (1) current conditions and trends within the biopharmaceutical industry complex; (2) challenges and opportunities presented by instabilities within the complex, and by trends and realities such as pharma’s gravitation into specialty areas and biotech’s lead product dependence; and (3) the implications for remodeling and deal making within and among both sectors.